Although we observed no significant differences in NOX4 expression levels (Fig 4A), hypox-visASCs from MS subjects showed a statistically significant increase in NOX5 mRNA with respect to the other two groups of patients (Fig 4B). Here, NOX4 is linked to myeloid sarcoma.